FDA Finally Shuts Down Regeneca After Years of Ignored Warnings
A California dietary supplement company that repeatedly defied federal safety orders has agreed to shut down operations, ending a three-year legal battle with the Department of Justice.
Regeneca Worldwide and CEO Matthew Nicosia will cease all business activities under a settlement reached this month. The company's collapse marks the end of a regulatory nightmare that began when federal regulators discovered the firm was selling a weight-loss supplement laced with a banned stimulant.
The trouble started in August 2012 when the FDA sent Nicosia a warning letter about RegeneSlim, Regeneca's flagship product. Tests revealed the supplement contained dimethylamylamine, a powerful stimulant commonly used as a pre-workout aid. The problem: there was no evidence the ingredient was safe for human consumption or that it had been used in food or supplements before October 1994.
The FDA told Regeneca to stop selling RegeneSlim immediately. The company ignored the order and kept distributing the product anyway.
Two years later, the FDA tested RegeneSlim again and confirmed the dangerous ingredient was still present. Only then did Regeneca issue a voluntary recall in 2014, claiming they were investigating what went wrong. They never fixed the problem.
Dimethylamylamine, known as DMAA, narrows blood vessels and arteries, which can spike blood pressure and trigger serious heart problems. FDA warnings linked DMAA to shortness of breath, irregular heartbeats, chest pain, and heart attacks.
The government finally moved to force compliance. In 2015, the Department of Justice filed a lawsuit in the U.S. District Court for the Central District of California against VivaCeuticals Inc., the parent company doing business as Regeneca, seeking a permanent injunction to shut down operations.
Rather than fight the case, Regeneca capitulated and agreed to cease all business. The settlement represents a decisive victory for federal regulators who had spent years trying to prevent the company from selling untested and potentially lethal supplements to unsuspecting consumers.
The case underscores a persistent problem in the dietary supplement industry: companies that flout FDA regulations and bet that warnings will go unenforced. Regeneca's strategy nearly worked, but years of ignoring federal orders finally caught up with them.
🤖 Quick Answer
What led to Regeneca's shutdown by the FDA?Regeneca Worldwide shut down following a three-year legal battle with the Department of Justice over repeated FDA violations. The company sold RegeneSlim, a weight-loss supplement containing dimethylamylamine, a banned stimulant. Despite receiving a warning letter in August 2012, the company continued defying federal safety orders, ultimately leading to the settlement requiring cessation of operations.
Who was responsible for Regeneca's regulatory violations?
CEO Matthew Nicosia led Regeneca Worldwide during the period of FDA violations. Under the settlement agreement, both the company and Nicosia agreed to cease all business activities. Nicosia's failure to comply with federal safety orders and warning letters directly contributed to the regulatory action against the organization.
🔗 Related Articles
- $18.2 mill suspended judgment in FTC’s RengaLife case (updates)
- Eddy Alexandre’s initial court appearance and what’s next
- $314,228 Canadian Zeek net-winner’s $2800 settlement offer rejected
- Akashx: My Daily Choice’s “social trading” securities fraud
- DOJ opposes Eddy Alexandre’s change of bail conditions